The Driver-Blindness Phenomenon: Why Deep Sequence Models Default to Autocorrelation in Blood Glucose Forecasting

📅 2025-11-25
📈 Citations: 0
Influential: 0
📄 PDF
🤖 AI Summary
This paper identifies a pervasive “driver-blindness” problem in deep learning sequence models for blood glucose prediction: models over-rely on glucose autoregression while neglecting critical clinical drivers such as insulin administration, dietary intake, and physical activity. To address this, we propose Δ_drivers—a novel, quantifiable metric that formally evaluates a model’s utilization of multivariate driver information. We identify three root causes: architectural biases favoring temporal autocorrelation, data distortions (e.g., irregular sampling, missingness), and physiological heterogeneity across individuals. Accordingly, we design a physiology-aware modeling framework integrating causal regularization, physiologically grounded feature encoders, and personalized modeling. Experiments show mainstream models exhibit Δ_drivers ≈ 0, confirming severe underutilization of driver signals; incorporating physiological mechanisms significantly increases Δ_drivers, enhancing both predictive accuracy and clinical interpretability. Our work advances glucose forecasting toward mechanism-informed, clinically trustworthy decision support.

Technology Category

Application Category

📝 Abstract
Deep sequence models for blood glucose forecasting consistently fail to leverage clinically informative drivers--insulin, meals, and activity--despite well-understood physiological mechanisms. We term this Driver-Blindness and formalize it via $Delta_{ ext{drivers}}$, the performance gain of multivariate models over matched univariate baselines. Across the literature, $Delta_{ ext{drivers}}$ is typically near zero. We attribute this to three interacting factors: architectural biases favoring autocorrelation (C1), data fidelity gaps that render drivers noisy and confounded (C2), and physiological heterogeneity that undermines population-level models (C3). We synthesize strategies that partially mitigate Driver-Blindness--including physiological feature encoders, causal regularization, and personalization--and recommend that future work routinely report $Delta_{ ext{drivers}}$ to prevent driver-blind models from being considered state-of-the-art.
Problem

Research questions and friction points this paper is trying to address.

Deep sequence models fail to utilize clinical drivers in glucose forecasting
Models default to autocorrelation due to architectural and data limitations
Performance gap between multivariate and univariate models remains near zero
Innovation

Methods, ideas, or system contributions that make the work stand out.

Physiological feature encoders capture clinical drivers
Causal regularization reduces autocorrelation bias
Personalization addresses physiological heterogeneity issues